b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="globhlth" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1502134/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502134/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Globalization and Health" /><meta name="citation_title" content="Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States" /><meta name="citation_authors" content="Ruifang Zhang, Karen Eggleston, Vincent Rotimi, Richard J Zeckhauser" /><meta name="citation_date" content="2006" /><meta name="citation_volume" content="2" /><meta name="citation_firstpage" content="6" /><meta name="citation_doi" content="10.1186/1744-8603-2-6" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1502134/?report=abstract" /><meta name="citation_pmid" content="16603071" /><meta name="DC.Title" content="Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BioMed Central" /><meta name="DC.Contributor" content="Ruifang Zhang" /><meta name="DC.Contributor" content="Karen Eggleston" /><meta name="DC.Contributor" content="Vincent Rotimi" /><meta name="DC.Contributor" content="Richard J Zeckhauser" /><meta name="DC.Date" content="2006" /><meta name="DC.Identifier" content="10.1186/1744-8603-2-6" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States" /><meta property="og:type" content="article" /><meta property="og:description" content="Antimicrobial resistance is an under-appreciated threat to public health in nations around the globe. With globalization booming, it is important to understand international patterns of resistance. If countries already experience similar patterns of resistance, ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502134/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-globhlth.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1502134/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1502134/pdf/1744-8603-2-6.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A08BFE99A45910000000004F304F3.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/318/">Global Health</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/127943/">v.2; 2006</a></li><li class="accid">PMC1502134</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-globhlth.png" alt="Logo of globhlth" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher\'s site" title="Link to Publisher\'s site" shape="default" coords="0,0,499,74" href="https://globalizationandhealth.biomedcentral.com" target="pmc_ext" ref="reftype=publisher&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Global Health</span>. 2006; 2: 6. </span></div><div><span class="fm-vol-iss-date">Published online 2006 Apr 7. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1744-8603-2-6" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1744-8603-2-6</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1502134</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/16603071">16603071</a></div></div></div></div><h1 class="content-title">Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Zhang%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16603071" id="A1" class="affpopup" co-rid="_co_idm139927443327104" co-class="co-affbox">Ruifang Zhang</a>,<sup>1</sup> <a href="/pubmed/?term=Eggleston%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16603071" id="A2" class="affpopup" co-rid="_co_idm139927477664832" co-class="co-affbox">Karen Eggleston</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>2</sup> <a href="/pubmed/?term=Rotimi%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16603071" id="A3" class="affpopup" co-rid="_co_idm139927440276640" co-class="co-affbox">Vincent Rotimi</a>,<sup>3</sup> and  <a href="/pubmed/?term=Zeckhauser%20RJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16603071" id="A4" class="affpopup" co-rid="_co_idm139927513588368" co-class="co-affbox">Richard J Zeckhauser</a><sup>4</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139927443327104"><h3 class="no_margin">Ruifang Zhang</h3><p><sup>1</sup>Goldman Sachs International, Global Investment Research, London, UK</p><div>Find articles by <a href="/pubmed/?term=Zhang%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16603071">Ruifang Zhang</a></div></div><div id="_co_idm139927477664832"><h3 class="no_margin">Karen Eggleston</h3><p><sup>2</sup>Tufts University Economics Department, Medford, MA 02155, USA</p><div>Find articles by <a href="/pubmed/?term=Eggleston%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16603071">Karen Eggleston</a></div></div><div id="_co_idm139927440276640"><h3 class="no_margin">Vincent Rotimi</h3><p><sup>3</sup>Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait</p><div>Find articles by <a href="/pubmed/?term=Rotimi%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16603071">Vincent Rotimi</a></div></div><div id="_co_idm139927513588368"><h3 class="no_margin">Richard J Zeckhauser</h3><p><sup>4</sup>Harvard University Kennedy School of Government, Cambridge, MA, USA</p><div>Find articles by <a href="/pubmed/?term=Zeckhauser%20RJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16603071">Richard J Zeckhauser</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139927515202672_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139927515202672_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139927515202672_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139927515202672_ai" style="display:none"><div class="fm-affl" lang="en" id="I1"><sup>1</sup>Goldman Sachs International, Global Investment Research, London, UK</div><div class="fm-affl" lang="en" id="I2"><sup>2</sup>Tufts University Economics Department, Medford, MA 02155, USA</div><div class="fm-affl" lang="en" id="I3"><sup>3</sup>Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait</div><div class="fm-affl" lang="en" id="I4"><sup>4</sup>Harvard University Kennedy School of Government, Cambridge, MA, USA</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><span class="contrib-email" id="A1">Ruifang Zhang: <a href="mailto:dev@null" data-email="moc.sg@gnahz.gnafiur" class="oemail">moc.sg@gnahz.gnafiur</a>; </span> <span class="contrib-email" id="A2">Karen Eggleston: <a href="mailto:dev@null" data-email="ude.stfut@notselgge.nerak" class="oemail">ude.stfut@notselgge.nerak</a>; </span> <span class="contrib-email" id="A3">Vincent Rotimi: <a href="mailto:dev@null" data-email="WK.UDE.CSH@tnecniv" class="oemail">WK.UDE.CSH@tnecniv</a>; </span> <span class="contrib-email" id="A4">Richard J Zeckhauser: <a href="mailto:dev@null" data-email="ude.dravrah@resuahkcez_drahcir" class="oemail">ude.dravrah@resuahkcez_drahcir</a></span> </div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139927515202672_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2005 Sep 4; Accepted 2006 Apr 7.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139927515202672_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2006 Zhang et al; licensee BioMed Central Ltd.</div><div class="license half_rhythm"><p id="__p1">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/2.0" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/2.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1502134/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139927445289840" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139927445289840title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p2" class="p p-first-last">Antimicrobial resistance is an under-appreciated threat to public health in nations around the globe. With globalization booming, it is important to understand international patterns of resistance. If countries already experience similar patterns of resistance, it may be too late to worry about international spread. If large countries or groups of countries that are likely to leap ahead in their integration with the rest of the world &#x02013; China being the standout case &#x02013; have high and distinctive patterns of resistance, then a coordinated response could substantially help to control the spread of resistance. The literature to date provides only limited evidence on these issues.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p3" class="p p-first-last">We study the recent patterns of antibiotic resistance in three geographically separated, and culturally and economically distinct countries &#x02013; China, Kuwait and the United States &#x02013; to gauge the range and depth of this global health threat, and its potential for growth as globalization expands. Our primary measures are the prevalence of resistance of specific bacteria to specific antibiotics. We also propose and illustrate methods for aggregating specific "bug-drug" data. We use these aggregate measures to summarize the resistance pattern for each country and to study the extent of correlation between countries\' patterns of drug resistance.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p4" class="p p-first-last">We find that China has the highest level of antibiotic resistance, followed by Kuwait and the U.S. In a study of resistance patterns of several most common bacteria in China in 1999 and 2001, the mean prevalence of resistance among hospital-acquired infections was as high as 41% (with a range from 23% to 77%) and that among community- acquired infections was 26% (with a range from 15% to 39%). China also has the most rapid growth rate of resistance (22% average growth in a study spanning 1994 to 2000). Kuwait is second (17% average growth in a period from 1999 to 2003), and the U.S. the lowest (6% from 1999 to 2002). Patterns of resistance across the three countries are not highly correlated; the most correlated were China and Kuwait, followed by Kuwait and the U.S., and the least correlated pair was China and the U.S.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p5" class="p p-first-last">Antimicrobial resistance is a serious and growing problem in all three countries. To date, there is not strong international convergence in the countries\' resistance patterns. This finding may change with the greater international travel that will accompany globalization. Future research on the determinants of drug resistance patterns, and their international convergence or divergence, should be a priority.</p></div></div></div><div id="__sec5" class="tsec sec headless whole_rhythm"><p id="__p6" class="p p-first">In 1942, the first U.S. patient with streptococcal infection was miraculously cured with a small dose of penicillin. Sixty years later, penicillin-resistant Streptococcus is widespread. Such antimicrobial resistance threatens the health of many throughout the world, since both old and new infectious diseases remain a formidable public health threat.</p><p id="__p7">Among the issues that merit further scrutiny for understanding the possible spread of antimicrobial resistance, few are as salient as the impact of globalization. Clearly the movement of people and goods around the globe contributes to transmission of disease [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916170">1</a>,<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916171">2</a>]. To what extent drug resistance and globalization are similarly related remains unclear. The breakout of Severe Acute Respiratory Syndrome (SARS) in the spring of 2003 illustrates how an infectious disease with limited therapeutic options can spread rapidly across national borders. With globalization booming, it is important to understand international patterns of resistance. If countries already experience similar patterns of resistance, it may be too late to worry about international spread. If large countries or groups of countries that are likely to leap ahead in their integration with the rest of the world &#x02013; China being the standout case &#x02013; have high and distinctive patterns of resistance, then a coordinated response could help substantially to control the spread of resistance. The literature to date provides only limited evidence on these issues.</p><p id="__p8">We study the pattern of antibiotic resistance in specific countries to gauge the range and depth of this global health threat. China and the U.S. stand out as good choices for study. Both are world economic powerhouses increasingly responding to the forces of economic globalization. In addition, both are major consumers of antibiotics, with the U.S. also being a leading source of new antibiotics. On the other hand, it would also be interesting to compare patterns of antibiotic resistance in smaller countries that stand relatively distant from these two. Accordingly, we compare the experiences of the U.S. and China with new data on the resistance experience of Kuwait.</p><p id="__p9" class="p p-last">The first section gives brief background on antibiotic resistance and its costs. We then turn to a detailed comparison of surveillance data from China, Kuwait, and the U.S. We conclude with a plea for more research and attention on this critical issue for health and globalization.</p></div><div id="__sec6" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec6title">Background: The challenge of antimicrobial resistance</h2><p id="__p10" class="p p-first">According to laws of Darwinian evolution, antimicrobial use creates a selection pressure on microorganisms: weak ones are killed, but stronger ones might adapt and survive. When pathogenic microorganisms can multiply beyond some critical mass in the face of invading antimicrobials, treatment outcome is compromised; this phenomenon is referred as antimicrobial resistance (AMR) [<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916176">3</a>-<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916167">9</a>]. This paper focuses on antibiotic resistance, a major form of AMR.</p><p id="__p11">Resistance mechanisms may develop over months or years [<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916168">6</a>]. Once established, a single resistance mechanism can often allow a bacterium to resist multiple drugs. It remains unclear whether resistance is reversible, and thus whether drug effectiveness is a renewable or non-renewable resource [<a href="#B10" rid="B10" class=" bibr popnode">10</a>-<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916172">15</a>]. Drug resistance raises the cost of treatment for infectious diseases, sometimes manifold, as well as increasing morbidity and mortality from such diseases [<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916169">16</a>-<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916174">23</a>].</p><p id="__p12">The greatest long-term threat of AMR is that resistant strains erode drug efficacy over time. The development of drug-resistant <em>Staphylococci aureus </em>(SAU) well illustrates the see-saw battle between pathogens and drugs. SAU is a bacterium that harmlessly lives in the human body but can cause infections on wounds or lesions. After the clinical application of penicillin in the 1940s, SAU soon adapted to the treatment mechanism of penicillin, and by the 1950s, almost half of SAU strains had become resistant to penicillin. A new antibiotic, methicillin, was developed in the 1960s. Yet by the late 1970s, methicillin-resistant SAU, i.e. MRSA, again became widespread. Today MRSA has become a major infectious culprit that can only be effectively treated with vancomycin, one of the few last killers of superbugs. Unfortunately, in 1996, a Japanese hospital reported the first case of vancomycin-resistant SAU (VRSA) during surgery on a four-month-old boy. The U.S., France and Hong Kong subsequently all reported VRSA incidents. A few years later in 2000, linezolid was launched as a new antibiotic to combat both MRSA and VRSA. But only one year later, Boston researchers reported the first case of linezolid-resistant MRSA in an 85-year-old man undergoing peritoneal dialysis. After failing to contain his MRSA by linezolid, researchers tried five antibiotics (ampicillin, azithromycin, gentamicin, levofloxacin, and quinupristin-dalfopristin) but the unlucky man eventually died from the uncontrollable infection [<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916166">24</a>].</p><p id="__p13" class="p">Resistant pathogens within a hospital or specific community can spread to a nation at large or across national boundaries. Thus, for example, rapidly increasing travel and migration within China probably contributes to the growth of that nation\'s resistance problem. It may also spur the spread of China\'s resistance problems overseas as globalization greatly increases travel from and to that nation (see Figure <a href="/pmc/articles/PMC1502134/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1</span></span><span>1</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC1502134/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927434052752" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1502134_1744-8603-2-6-1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1744-8603-2-6-1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1502134/bin/1744-8603-2-6-1.jpg" /></a></div><div id="largeobj_idm139927434052752" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC1502134/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p14">Travel to and from China has increased tremendously over the past decade.</p></div></div></div></div><div id="__sec7" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec7title">Methods</h2><p id="__p15" class="p p-first">We collected data on drug resistance in China, the U.S. and Kuwait, drawing from published studies, reports from national surveillance systems, and previously unpublished data from a large hospital in Kuwait. Such data must be viewed with caution. Differences between countries arise not only from genuine differences in prevalence, but also from differences in sampling strategies, laboratory processing, and standards for defining a "resistant" strain. Moreover, within-country comparisons across time are biased by measurement error, particularly for small samples. However, analysis of the currently available data does yield some evidence and may help to raise awareness and efforts to improve the data and methods for addressing the problem.</p><p id="__p16">Our primary measure is the prevalence of resistance by a specific bacterium to a specific drug. The prevalence is calculated as the number of resistant isolates divided by the number of total isolates collected, multiplied by 100. We compute growth rates of resistance to specific bacteria using standard year-on-year growth calculations. Where appropriate, we smooth variance in small-sample data series by using three-year running averages.</p><p id="__p17">We also develop methods to aggregate specific "bug-drug" data to summarize the resistance pattern for each country. These measures weight resistance rates by (1) the isolation frequency for each bacterium (that is, the proportion of a particular bacterium among all bacteria studied); and, where possible, by (2) the proportion of resistant cases hospital- versus community-acquired; and (3) the frequency with which each drug is used to treat infections caused by each bacterium. (For most calculations, measure (3) is not available.) Finally, we compare and contrast each country\'s resistance experience and, using the subset of data comparable across the three countries, examine correlations in patterns of resistance.</p><p id="__p18" class="p p-last">These methods represent preliminary steps to gauge whether patterns of antibiotic resistance converge over time amongst countries that currently have little population interchange. Future research would benefit from better surveillance of resistance, more comparable data reporting, data on antibiotic utilization, and further methodological advances in clinically- and policy-relevant aggregation of "bug-drug" data.</p></div><div id="__sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec8title">Results</h2><div id="__sec9" class="sec sec-first"><h3 id="__sec9title">China</h3><p id="__p19" class="p p-first">In 1988, the World Health Organization West Pacific Regional Office set up two antimicrobial resistance surveillance centers in Beijing and Shanghai. Meanwhile, China\'s Ministry of Health also established the China Nosocomial Infection Surveillance (CNIS) program, which monitors hospital-acquired infections. Unfortunately, most of the surveillance programs in China focus on urban hospitals. We lack data on urban communities and for the rural majority. Nevertheless, the available data allows us to piece together a picture of the extent of antimicrobial resistance in the most populous country in the world.</p><p id="__p20">To examine AMR development in China, we use annual data from a seven-year (1994&#x02013;2000) study by China\'s National Center for Antimicrobial Resistance, which reports resistance levels of ten most prevalent bacteria to a common antibiotic, ciprofloxacin (Table <a href="/pmc/articles/PMC1502134/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1)</span></span><span>1</span></a>) [<a href="#B25" rid="B25" class=" bibr popnode">25</a>]. With small sample sizes, the annual measured percentage of isolates found to be resistant varies considerably; to smooth the random variation attributable to small sample size, we use three-year running averages. Some bacteria such as ECO and MRSA have high proportions (60&#x02013;80%) of resistant strains, whereas the prevalence of resistant strains for others such as PMI is quite low. Almost all but MSSA and PMI have shown considerable growth in resistance over the study period, resulting in an average annual growth rate of about 15%.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p21">Resistance prevalence of ten common bacteria to Ciprofloxacin in China, 1994&#x02013;2000</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927514495328" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="right" colspan="12" rowspan="1"><strong>unit: %</strong></td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Rank</td><td align="center" rowspan="1" colspan="1">Bacter.</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">1994</td><td align="center" rowspan="1" colspan="1">1995</td><td align="center" rowspan="1" colspan="1">1996</td><td align="center" rowspan="1" colspan="1">1997</td><td align="center" rowspan="1" colspan="1">1998</td><td align="center" rowspan="1" colspan="1">1999</td><td align="center" rowspan="1" colspan="1">2000</td><td align="center" rowspan="1" colspan="1"><strong><em>Average Resistance*</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>Average Growth Rate*</em></strong></td></tr><tr><td colspan="12" rowspan="1"><hr /></td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Escherichia coli (ECO)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">49</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1"><strong><em>59</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>3</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">Pseudomonas aeruginosa (PAE)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1"><strong><em>13</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>17</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">Klebsiella pneumoniae (KPN)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1"><strong><em>10</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>40</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">Staphylococci epidermidis (SEP)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1"><strong><em>36</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>9</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">Staphylococci aureus (SAU)</td><td align="center" rowspan="1" colspan="1">MRSA**</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">88</td><td align="center" rowspan="1" colspan="1">83</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">76</td><td align="center" rowspan="1" colspan="1"><strong><em>76</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>7</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">MSSA**</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1"><strong><em>11</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>8</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">Enterococcus faecalis (EFA)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1"><strong><em>34</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>9</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">Enterobacter cloacae (ECL)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1"><strong><em>18</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>26</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">Acinetobacter baumannii (ABA)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1"><strong><em>20</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>29</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">Citrobacter freundii (CFR)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1"><strong><em>20</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>10</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">Proteus mirabilis (PMI)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1"><strong><em>7</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>10</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><strong><em>Mean</em></strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><strong><em>28</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>15</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><strong><em>Median</em></strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><strong><em>20</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>10</em></strong></td></tr></tbody></table></div><div id="largeobj_idm139927514495328" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p22">* Based on three-year running averages.</p><p id="__p23">** Staphylococci aureus (SAU) is further grouped as methicillin susceptible staphylococci aureus (MSSA) and methicillin resistant staphylococci aureus (MRSA).</p></div></div><p id="__p24">Another series of studies by the China Bacterial Resistance Surveillance Study Group focused on resistance prevalence among different patient types, i.e. those with hospital-acquired infections (HAI) versus community-acquired infections (CAI) [<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_341799523">26</a>,<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_341799524">27</a>]. We construct two measures to compare HAI and CAI resistance prevalence. First, by aggregating the seven bacteria, we get a measure &#x003b3; indexed on the nineteen drugs. &#x003b3; is calculated by multiplying the resistance rate of each bacterium by its isolation frequency and proportion among HAI (or CAI) infections, and then summing across bacteria. The measure is reported in the last two columns of Table <a href="/pmc/articles/PMC1502134/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table2</span></span><span>2</span></a> and graphed in Figure <a href="/pmc/articles/PMC1502134/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure2.</span></span><span>2</span></a>. Second, by aggregating the drugs, we obtain a measure indexed on bacteria. However, because we lack data on how often each drug is used, the best we can do is report the simple average for all drugs (implicitly assuming each drug is used with equal frequency). We name this measure Mean Resistance, shown in the last row in Table <a href="/pmc/articles/PMC1502134/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table2</span></span><span>2</span></a> and graphed in Figure <a href="/pmc/articles/PMC1502134/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure3</span></span><span>3</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p25">Resistance patterns of the seven most common bacteria for Hospital-acquired Infections (HAI) and Community-acquired Infections (CAI), China 2001</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927443998176" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="right" colspan="17" rowspan="1">unit: %</td></tr><tr><td rowspan="1" colspan="1"></td><td colspan="16" rowspan="1"><hr /></td></tr><tr><td align="center" rowspan="1" colspan="1">Antibiotic(s)</td><td align="center" colspan="2" rowspan="1">SAU (n = 176)</td><td align="center" colspan="2" rowspan="1">SEP (n = 84)</td><td align="center" colspan="2" rowspan="1">ECO (n = 308)</td><td align="center" colspan="2" rowspan="1">ECL (n = 78)</td><td align="center" colspan="2" rowspan="1">PAE (n = 232)</td><td align="center" colspan="2" rowspan="1">KPN (n = 215)</td><td align="center" colspan="2" rowspan="1">ABA (n = 191)</td><td align="center" colspan="2" rowspan="1">&#x003b3;</td></tr></thead><tbody><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">HAI (37)</td><td align="center" rowspan="1" colspan="1">CAI (139)</td><td align="center" rowspan="1" colspan="1">HAI (14)</td><td align="center" rowspan="1" colspan="1">CAI (70)</td><td align="center" rowspan="1" colspan="1">HAI (44)</td><td align="center" rowspan="1" colspan="1">CAI (264)</td><td align="center" rowspan="1" colspan="1">HAI (27)</td><td align="center" rowspan="1" colspan="1">CAI (51)</td><td align="center" rowspan="1" colspan="1">HAI (95)</td><td align="center" rowspan="1" colspan="1">CAI (137)</td><td align="center" rowspan="1" colspan="1">HAI (48)</td><td align="center" rowspan="1" colspan="1">CAI (167)</td><td align="center" rowspan="1" colspan="1">HAI (46)</td><td align="center" rowspan="1" colspan="1">CAI (145)</td><td align="center" rowspan="1" colspan="1"><strong><em>HAI</em></strong>&#x003b3;<sub><em>H</em></sub></td><td align="center" rowspan="1" colspan="1"><strong><em>CAI</em></strong>&#x003b3;<sub><em>C</em></sub></td></tr><tr><td colspan="17" rowspan="1"><hr /></td></tr><tr><td align="center" rowspan="1" colspan="1">Methicillin</td><td align="center" rowspan="1" colspan="1">89</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1"><strong><em>11</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>5</em></strong></td></tr><tr><td colspan="17" rowspan="1"><hr /></td></tr><tr><td align="center" rowspan="1" colspan="1">Ampicillin</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">82</td><td align="center" rowspan="1" colspan="1">86</td><td align="center" rowspan="1" colspan="1">67</td><td align="center" rowspan="1" colspan="1">89</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1"><strong><em>38</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>35</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Amoxicillin</td><td align="center" rowspan="1" colspan="1">89</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">84</td><td align="center" rowspan="1" colspan="1">81</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">94</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">95</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1"><strong><em>38</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>31</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Ceftizoxime</td><td align="center" rowspan="1" colspan="1">87</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">96</td><td align="center" rowspan="1" colspan="1">86</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">96</td><td align="center" rowspan="1" colspan="1">92</td><td align="center" rowspan="1" colspan="1"><strong><em>24</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>16</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Cefaclor</td><td align="center" rowspan="1" colspan="1">87</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">89</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1"><strong><em>23</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>15</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Cefuroxime</td><td align="center" rowspan="1" colspan="1">89</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1"><strong><em>22</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>12</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Cefprozil.</td><td align="center" rowspan="1" colspan="1">87</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">94</td><td align="center" rowspan="1" colspan="1">86</td><td align="center" rowspan="1" colspan="1"><strong><em>24</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>15</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Ceftazidime</td><td align="center" rowspan="1" colspan="1">92</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1"><strong><em>19</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>8</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Cefotaxime</td><td align="center" rowspan="1" colspan="1">84</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1"><strong><em>15</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>8</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1">89</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1"><strong><em>18</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>8</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Imipenem</td><td align="center" rowspan="1" colspan="1">76</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"><strong><em>8</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>2</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Meropenem</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1"><strong><em>8</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>2</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Ciprofloxacin</td><td align="center" rowspan="1" colspan="1">87</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1"><strong><em>29</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>18</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Ofloxacin</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1"><strong><em>27</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>18</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Levofloxacin</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1"><strong><em>21</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>13</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Sparfloxacin</td><td align="center" rowspan="1" colspan="1">89</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1"><strong><em>32</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>21</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Moxifloxacin</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1"><strong><em>17</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>12</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Gatifloxacin</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1"><strong><em>13</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>7</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Gentamicin</td><td align="center" rowspan="1" colspan="1">87</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1"><strong><em>25</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>16</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1"><strong><em>Mean Resistance</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>77</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>28</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>30</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>15</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>42</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>34</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>54</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>39</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>26</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>18</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>23</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>20</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>35</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>28</em></strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm139927443998176" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T2/?report=objectonly">Open in a separate window</a></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC1502134/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927476544560" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1502134_1744-8603-2-6-2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1744-8603-2-6-2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1502134/bin/1744-8603-2-6-2.jpg" /></a></div><div id="largeobj_idm139927476544560" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC1502134/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p26">Hospital-acquired infections (HAI) are more resistant than community-acquired infections (CAI) to a wide range of antibiotics in China.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC1502134/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927437144864" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1502134_1744-8603-2-6-3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1744-8603-2-6-3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1502134/bin/1744-8603-2-6-3.jpg" /></a></div><div id="largeobj_idm139927437144864" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC1502134/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p27">The Seven most common bacteria show higher resistance among hospital-acquired infections (HAI) than community-acquired infections (CAI) in China.</p></div></div></div><p id="__p28" class="p p-last">Both measures reinforce the finding that infections acquired in a hospital are often more drug resistant than other (community-acquired) infections. For the seven bacteria, the mean resistance rate of HAI is on average 1.5 times that of CAI in China. For the nineteen drugs, the aggregate measure of resistance for HAI, &#x003b3;<sub><em>H</em></sub>, is on average 1.9 times that for CAI, &#x003b3;<sub><em>C</em></sub>. This pattern is most extreme for infections caused by SAU, where resistance of HAI is two- to three- times that of CAI, depending on which measure is used. (T-tests of the difference between two groups indicate a p-value of less than 0.01 for the &#x003b3;\'s and less than 0.09 for the mean resistance). Moreover, the prevalence of drug resistance for both kinds of infections is quite high. Mean resistance of HAI is 41% and that of CAI is 28%.</p></div><div id="__sec10" class="sec"><h3 id="__sec10title">United States</h3><p id="__p29" class="p p-first">Fairly comprehensive data on resistance trends in the U.S. come from the National Nosocomial Infections Surveillance System (NNIS) for hospital-based resistance, and the U.S. Active Bacterial Core Surveillance (ABC) project, which surveys a population of 16 million to 25 million community residents in 9 states each year [<a href="#B28" rid="B28" class=" bibr popnode">28</a>-<a href="#B30" rid="B30" class=" bibr popnode">30</a>]. We use data from an ABC program that surveys <em>Streptococcus pneumoniae </em>(SPN) from 1997 to 2002 to examine prevalence and trends (Table <a href="/pmc/articles/PMC1502134/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table3).</span></span><span>3</span></a>). The average growth rate of resistance for this bacterium was 8%, lower than the 15% number for China. Interestingly, unlike the upward resistance trend in China, SPN resistance declined in the last two years of the study period in the US, following an initial rise. Such data should not be interpreted to mean that actual prevalence is permanently declining, since measurement issues engender considerable year-to-year variation in the sample prevalence.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p30">Non-susceptibilities of <em>Streptococcus pneumoniae </em>(SPN) in U.S. communities, 1997&#x02013;2002</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927436347312" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" colspan="9" rowspan="1">Unit: %</td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Antibiotic</td><td align="center" rowspan="1" colspan="1">1997</td><td align="center" rowspan="1" colspan="1">1998</td><td align="center" rowspan="1" colspan="1">1999</td><td align="center" rowspan="1" colspan="1">2000</td><td align="center" rowspan="1" colspan="1">2001</td><td align="center" rowspan="1" colspan="1">2002</td><td align="center" rowspan="1" colspan="1"><strong><em>Average Resistance</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>Average Growth Rate</em></strong></td></tr><tr><td colspan="9" rowspan="1"><hr /></td></tr><tr><td align="center" rowspan="1" colspan="1">Penicillin</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1"><strong><em>25</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>2</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Cefotaxime</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1"><strong><em>15</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>-1</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Erythromycin</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1"><strong><em>18</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>4</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">TMP/Sulfa</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1"><strong><em>30</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>-3</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Levofloxacin</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">0.2</td><td align="center" rowspan="1" colspan="1">0.2</td><td align="center" rowspan="1" colspan="1">0.3</td><td align="center" rowspan="1" colspan="1">0.7</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1"><strong><em>0.4</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>39</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Vancomycin</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1"><strong><em>18</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>8</em></strong></td></tr></tbody></table></div><div id="largeobj_idm139927436347312" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T3/?report=objectonly">Open in a separate window</a></div></div><p id="__p31">The US NNIS program provides data for inpatients and outpatients. Further, among inpatients, the NNIS differentiates between those in and not in the ICU. For almost every bug-drug pair, resistance prevalence is highest among ICU patients, followed by non-ICU inpatients, with the lowest prevalence among outpatients (Table <a href="/pmc/articles/PMC1502134/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table4</span></span><span>4</span></a> and Figure <a href="/pmc/articles/PMC1502134/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure4).</span></span><span>4</span></a>). This pattern seems consistent with clinical reality, since patients in ICUs are more likely to have a weak immune system, either because of prolonged treatment or their own compromised conditions; moreover, many are catheterized, offering a conduit for bacteria.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="__p32">Resistance prevalence for selected drug-bug pairs by patient type, U.S. 1999&#x02013;2002</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927443089936" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" colspan="5" rowspan="1">unit: %</td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Pair</td><td align="center" rowspan="1" colspan="1">Bacterium (resistant to) &#x02192; drug</td><td align="center" rowspan="1" colspan="1">ICU patients</td><td align="center" rowspan="1" colspan="1">non-ICU inpatients</td><td align="center" rowspan="1" colspan="1">Outpatients</td></tr><tr><td colspan="5" rowspan="1"><hr /></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">PAE &#x02192; Ciprofloxacin/ofloxacin</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">23</td></tr><tr><td align="center" rowspan="1" colspan="1">B</td><td align="center" rowspan="1" colspan="1">PAE &#x02192; Levofloxacin</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">25</td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">PAE &#x02192; Imipenem</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">9</td></tr><tr><td align="center" rowspan="1" colspan="1">D</td><td align="center" rowspan="1" colspan="1">PAE &#x02192; Ceftazidime</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td align="center" rowspan="1" colspan="1">E</td><td align="center" rowspan="1" colspan="1">PAE &#x02192; Piperacillin</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td align="center" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">SAU &#x02192; Methicillin</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">23</td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">Enterococcus spp &#x02192; Vancomycin</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="center" rowspan="1" colspan="1">H</td><td align="center" rowspan="1" colspan="1">ECO &#x02192; Cef3*</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">I</td><td align="center" rowspan="1" colspan="1">ECO &#x02192; Quinolone**</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="center" rowspan="1" colspan="1">J</td><td align="center" rowspan="1" colspan="1">KPN &#x02192; Cef3</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="center" rowspan="1" colspan="1">K</td><td align="center" rowspan="1" colspan="1">Enterobacter spp &#x02192; Cef3</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="center" rowspan="1" colspan="1">L</td><td align="center" rowspan="1" colspan="1">Enterobacter spp &#x02192; Carbapenum</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">CNS &#x02192; Methicillin</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">46</td></tr><tr><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">Pneumococcus &#x02192; Penicillin</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">17</td></tr><tr><td align="center" rowspan="1" colspan="1">O</td><td align="center" rowspan="1" colspan="1">Pneumococcus &#x02192; Cef3</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><strong><em>Mean</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>21</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>17</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>12</em></strong></td></tr></tbody></table></div><div id="largeobj_idm139927443089936" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p33">*Cef3 (3<sup>rd </sup>generation cephalosporin) = ceftazidime, cefotaxime or ceftriaxone;</p><p id="__p34">**Quinolone = ciprofloxacin, ofloxacin or levofloxacin.</p></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC1502134/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927477426720" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1502134_1744-8603-2-6-4.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1744-8603-2-6-4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1502134/bin/1744-8603-2-6-4.jpg" /></a></div><div id="largeobj_idm139927477426720" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC1502134/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p35">ICU patients have the highest resistance rates in selected drug-bug pairs, followed by non-ICU inpatients and outpatients, U.S. 1999&#x02013;2002.</p></div></div></div><p id="__p36">Compared with China, the U.S. exhibits more moderate differences in resistance prevalence among different patients. The average prevalence of resistance for ICU, other inpatients, and outpatients in the U.S. are 20%, 17% and 13%, respectively; in China, average resistance for hospital-acquired infections is 41% and that for community-acquired infections is 28%.</p><p id="__p37" class="p">Pooling all patients together (Table <a href="/pmc/articles/PMC1502134/table/T5/" target="table" class="fig-table-link figpopup" rid-figpopup="T5" rid-ob="ob-T5" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table5),</span></span><span>5</span></a>), we find the prevalence of resistance and its growth to be 17% and 7% respectively, consistent with our previous observation that the U.S. seems to have both lower resistance prevalence and less dramatic increase in resistance than China does.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T5"><h3>Table 5</h3><!--caption a7--><div class="caption"><p id="__p38">Resistance prevalence of eight common bacteria, U.S. (all patients pooled), 1999&#x02013;2002</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927439177984" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" colspan="9" rowspan="1">unit: %</td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Bacterium</td><td align="center" rowspan="1" colspan="1">Resistant to antibiotic(s)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">1999</td><td align="center" rowspan="1" colspan="1">2000</td><td align="center" rowspan="1" colspan="1">2001</td><td align="center" rowspan="1" colspan="1">2002</td><td align="center" rowspan="1" colspan="1"><strong><em>Average Resistance</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>Average Growth Rate</em></strong></td></tr><tr><td colspan="9" rowspan="1"><hr /></td></tr><tr><td align="center" rowspan="1" colspan="1">PAE</td><td align="center" rowspan="1" colspan="1">Ciprofloxacin/ofloxacin</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1"><strong><em>26</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>8</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Levofloxacin</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1"><strong><em>30</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>1</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Imipenem</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1"><strong><em>13</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>4</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ceftazidime</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1"><strong><em>9</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>4</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Piperacillin</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1"><strong><em>11</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>6</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">SAU (MRSA)</td><td align="center" rowspan="1" colspan="1">Methicillin</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1"><strong><em>36</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>7</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Enterococcus spp</td><td align="center" rowspan="1" colspan="1">Vancomycin</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1"><strong><em>10</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>-1</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">ECO</td><td align="center" rowspan="1" colspan="1">Cef3</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"><strong><em>1</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>0</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Quinolone</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1"><strong><em>4</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>36</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">KPN</td><td align="center" rowspan="1" colspan="1">Cef3</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1"><strong><em>4</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>8</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Enterobacter spp</td><td align="center" rowspan="1" colspan="1">Cef3</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1"><strong><em>19</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>0</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Carbapenum</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"><strong><em>1</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>0</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">CNS</td><td align="center" rowspan="1" colspan="1">Methicillin</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1"><strong><em>62</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>2</em></strong></td></tr><tr><td align="center" rowspan="1" colspan="1">Pneumococcus spp</td><td align="center" rowspan="1" colspan="1">Penicillin</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1"><strong><em>17</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>11</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Cef3</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1"><strong><em>7</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>16</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><strong><em>Mean:</em></strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><strong><em>17</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>7</em></strong></td></tr></tbody></table></div><div id="largeobj_idm139927439177984" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T5/?report=objectonly">Open in a separate window</a></div></div></div><div id="__sec11" class="sec sec-last"><h3 id="__sec11title">Kuwait</h3><p id="__p39" class="p p-first">There is considerably less detailed data on antibiotic resistance for Kuwait than for China or the U.S. We gathered data on antimicrobial resistance among isolates of eight different bacterial diseases over the most recent five years. The data is based on surveillance from a single large teaching hospital, Mubarak Al-Kabeer Hospital, which serves a catchment area representing about 60% of Kuwait\'s population. We report that data for the first time here and in a companion paper [<a href="#B31" rid="B31" class=" bibr popnode">31</a>] (see Tables <a href="/pmc/articles/PMC1502134/table/T6/" target="table" class="fig-table-link figpopup" rid-figpopup="T6" rid-ob="ob-T6" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Tables6,</span></span><span>6</span></a>, <a href="/pmc/articles/PMC1502134/table/T7/" target="table" class="fig-table-link figpopup" rid-figpopup="T7" rid-ob="ob-T7" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">,7,</span></span><span>7</span></a>, <a href="/pmc/articles/PMC1502134/table/T8/" target="table" class="fig-table-link figpopup" rid-figpopup="T8" rid-ob="ob-T8" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">,8,</span></span><span>8</span></a>, <a href="/pmc/articles/PMC1502134/table/T9/" target="table" class="fig-table-link figpopup" rid-figpopup="T9" rid-ob="ob-T9" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">,9).The</span></span><span>9</span></a>).The average resistance level for all surveyed bacteria was about 27% from 1999 to 2003 (Table <a href="/pmc/articles/PMC1502134/table/T10/" target="table" class="fig-table-link figpopup" rid-figpopup="T10" rid-ob="ob-T10" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table10),</span></span><span>10</span></a>), higher than the 17% for the U.S. and about the same as the 28% China. As for the other two countries, resistance appears to be growing in Kuwait.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T6"><h3>Table 6</h3><!--caption a7--><div class="caption"><p id="__p40">Resistance trend in isolates of <em>Salmonella </em>spp. over 5 years in Kuwait</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927442132704" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" rowspan="1" colspan="1">Antibiotic</td><td align="center" colspan="5" rowspan="1">Percentage (%) of resistant isolates in:</td></tr><tr><td rowspan="1" colspan="1"></td><td colspan="5" rowspan="1"><hr /></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">1999 (n = 216)</td><td align="center" rowspan="1" colspan="1">2000 (n = 215)</td><td align="center" rowspan="1" colspan="1">2001 (n = 129)</td><td align="center" rowspan="1" colspan="1">2002 (n = 167)</td><td align="center" rowspan="1" colspan="1">2003 (n = 165)</td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Amikacin</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Ampicillin</td><td align="right" rowspan="1" colspan="1">6</td><td align="right" rowspan="1" colspan="1">12</td><td align="right" rowspan="1" colspan="1">7</td><td align="right" rowspan="1" colspan="1">25</td><td align="right" rowspan="1" colspan="1">26</td></tr><tr><td align="center" rowspan="1" colspan="1">Amoxicillin-clavulanate</td><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">10</td><td align="right" rowspan="1" colspan="1">7</td><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Cefotaxime</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Cefuroxime</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">27</td><td align="right" rowspan="1" colspan="1">41</td></tr><tr><td align="center" rowspan="1" colspan="1">Cephalexin</td><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">10</td><td align="right" rowspan="1" colspan="1">37</td><td align="right" rowspan="1" colspan="1">57</td><td align="right" rowspan="1" colspan="1">50</td></tr><tr><td align="center" rowspan="1" colspan="1">Chloramphenicol</td><td align="right" rowspan="1" colspan="1">8</td><td align="right" rowspan="1" colspan="1">21</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">18</td><td align="right" rowspan="1" colspan="1">18</td></tr><tr><td align="center" rowspan="1" colspan="1">Ciprofloxacin</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">14</td><td align="right" rowspan="1" colspan="1">10</td><td align="right" rowspan="1" colspan="1">16</td></tr><tr><td align="center" rowspan="1" colspan="1">TMP/SMX</td><td align="right" rowspan="1" colspan="1">8</td><td align="right" rowspan="1" colspan="1">8</td><td align="right" rowspan="1" colspan="1">10</td><td align="right" rowspan="1" colspan="1">20</td><td align="right" rowspan="1" colspan="1">20</td></tr><tr><td align="center" rowspan="1" colspan="1">Gentamicin</td><td align="right" rowspan="1" colspan="1">6</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">42</td><td align="right" rowspan="1" colspan="1">42</td></tr><tr><td align="center" rowspan="1" colspan="1">Imipenem</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Meropenem</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Piperacillin</td><td align="right" rowspan="1" colspan="1">6</td><td align="right" rowspan="1" colspan="1">13</td><td align="right" rowspan="1" colspan="1">13</td><td align="right" rowspan="1" colspan="1">23</td><td align="right" rowspan="1" colspan="1">25</td></tr><tr><td align="center" rowspan="1" colspan="1">Piperacillin/tazobactam</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td></tr></tbody></table></div><div id="largeobj_idm139927442132704" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T6/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p41">No ESBL-producing strain has been isolated so far</p></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T7"><h3>Table 7</h3><!--caption a7--><div class="caption"><p id="__p42">Resistance trend in isolates of <em>Streptococcus pneumoniae </em>over a 5-year period in Kuwait</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927441517776" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" rowspan="1" colspan="1">Antibiotics</td><td align="center" colspan="5" rowspan="1">Percentage (%) of resistant isolates in:</td></tr><tr><td rowspan="1" colspan="1"></td><td colspan="5" rowspan="1"><hr /></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">1999 (n = 78)</td><td align="center" rowspan="1" colspan="1">2000 (n = 61)</td><td align="center" rowspan="1" colspan="1">2001 (n = 73)</td><td align="center" rowspan="1" colspan="1">2002 (n = 66)</td><td align="center" rowspan="1" colspan="1">2003 (n = 90)</td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Cefotaxime</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">6</td></tr><tr><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">4</td></tr><tr><td align="center" rowspan="1" colspan="1">Cefuroxime</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">8</td><td align="right" rowspan="1" colspan="1">9</td><td align="right" rowspan="1" colspan="1">41</td></tr><tr><td align="center" rowspan="1" colspan="1">Cephalexin</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">NT</td><td align="right" rowspan="1" colspan="1">NT</td><td align="right" rowspan="1" colspan="1">NT</td></tr><tr><td align="center" rowspan="1" colspan="1">Chloramphenicol</td><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">25</td><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Erythromycin</td><td align="right" rowspan="1" colspan="1">16</td><td align="right" rowspan="1" colspan="1">20</td><td align="right" rowspan="1" colspan="1">23</td><td align="right" rowspan="1" colspan="1">26</td><td align="right" rowspan="1" colspan="1">30</td></tr><tr><td align="center" rowspan="1" colspan="1">Imipenem</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Penicillin</td><td align="right" rowspan="1" colspan="1">32</td><td align="right" rowspan="1" colspan="1">38</td><td align="right" rowspan="1" colspan="1">46</td><td align="right" rowspan="1" colspan="1">52</td><td align="right" rowspan="1" colspan="1">54</td></tr><tr><td align="center" rowspan="1" colspan="1">Teicoplanin</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Vancomycin</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td></tr></tbody></table></div><div id="largeobj_idm139927441517776" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T7/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p43">NT = not tested</p></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T8"><h3>Table 8</h3><!--caption a7--><div class="caption"><p id="__p44">Percentage of <em>Enterococcus </em>species resistant to often-tested antibiotics over 5 years in Kuwait</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927444315584" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" rowspan="1" colspan="1">Antibiotic</td><td align="center" colspan="5" rowspan="1">Percentage (%) of resistant isolates in:</td></tr><tr><td rowspan="1" colspan="1"></td><td colspan="5" rowspan="1"><hr /></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">1999 (n = 370)</td><td align="center" rowspan="1" colspan="1">2000 (n = 335)</td><td align="center" rowspan="1" colspan="1">2001 (n = 322)</td><td align="center" rowspan="1" colspan="1">2002 (n = 248)</td><td align="center" rowspan="1" colspan="1">2003 (n = 212)</td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Ampicillin</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Erythromycin</td><td align="right" rowspan="1" colspan="1">59</td><td align="right" rowspan="1" colspan="1">78</td><td align="right" rowspan="1" colspan="1">77</td><td align="right" rowspan="1" colspan="1">75</td><td align="right" rowspan="1" colspan="1">92</td></tr><tr><td align="center" rowspan="1" colspan="1">Gentamicin</td><td align="right" rowspan="1" colspan="1">26</td><td align="right" rowspan="1" colspan="1">36</td><td align="right" rowspan="1" colspan="1">61</td><td align="right" rowspan="1" colspan="1">52</td><td align="right" rowspan="1" colspan="1">98</td></tr><tr><td align="center" rowspan="1" colspan="1">Nitrofurantoin</td><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">36</td><td align="right" rowspan="1" colspan="1">86</td></tr><tr><td align="center" rowspan="1" colspan="1">Norfloxacin</td><td align="right" rowspan="1" colspan="1">36</td><td align="right" rowspan="1" colspan="1">47</td><td align="right" rowspan="1" colspan="1">47</td><td align="right" rowspan="1" colspan="1">NT</td><td align="right" rowspan="1" colspan="1">NT</td></tr><tr><td align="center" rowspan="1" colspan="1">Penicillin</td><td align="right" rowspan="1" colspan="1">16</td><td align="right" rowspan="1" colspan="1">38</td><td align="right" rowspan="1" colspan="1">35</td><td align="right" rowspan="1" colspan="1">53</td><td align="right" rowspan="1" colspan="1">85</td></tr><tr><td align="center" rowspan="1" colspan="1">Teicoplanin</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">Vancomycin</td><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">0</td></tr></tbody></table></div><div id="largeobj_idm139927444315584" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T8/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p45">NT = not tested</p></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T9"><h3>Table 9</h3><!--caption a7--><div class="caption"><p id="__p46">Percentage of <em>Staphylococcus aureus </em>resistant to often-tested antibiotics over 5 years in Kuwait</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927446485728" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" rowspan="1" colspan="1">Antibiotic</td><td align="center" colspan="5" rowspan="1">Percentage (%) of resistant isolates in:</td></tr><tr><td rowspan="1" colspan="1"></td><td colspan="5" rowspan="1"><hr /></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">1999 (n = 648)</td><td align="center" rowspan="1" colspan="1">2000 (n = 595)</td><td align="center" rowspan="1" colspan="1">2001 (n = 484)</td><td align="center" rowspan="1" colspan="1">2002 (n = 420)</td><td align="center" rowspan="1" colspan="1">2003 (n = 286)</td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Ampicillin</td><td align="right" rowspan="1" colspan="1">96</td><td align="right" rowspan="1" colspan="1">100</td><td align="right" rowspan="1" colspan="1">98</td><td align="right" rowspan="1" colspan="1">96</td><td align="right" rowspan="1" colspan="1">98</td></tr><tr><td align="center" rowspan="1" colspan="1">Amoxicillin-clavulanic acid</td><td align="right" rowspan="1" colspan="1">6</td><td align="right" rowspan="1" colspan="1">33</td><td align="right" rowspan="1" colspan="1">27</td><td align="right" rowspan="1" colspan="1">22</td><td align="right" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">Cephalexin</td><td align="right" rowspan="1" colspan="1">33</td><td align="right" rowspan="1" colspan="1">30</td><td align="right" rowspan="1" colspan="1">25</td><td align="right" rowspan="1" colspan="1">36</td><td align="right" rowspan="1" colspan="1">34</td></tr><tr><td align="center" rowspan="1" colspan="1">Ciprofloxacin</td><td align="right" rowspan="1" colspan="1">10</td><td align="right" rowspan="1" colspan="1">35</td><td align="right" rowspan="1" colspan="1">30</td><td align="right" rowspan="1" colspan="1">45</td><td align="right" rowspan="1" colspan="1">50</td></tr><tr><td align="center" rowspan="1" colspan="1">Clindamycin</td><td align="right" rowspan="1" colspan="1">18</td><td align="right" rowspan="1" colspan="1">24</td><td align="right" rowspan="1" colspan="1">20</td><td align="right" rowspan="1" colspan="1">20</td><td align="right" rowspan="1" colspan="1">27</td></tr><tr><td align="center" rowspan="1" colspan="1">Cloxacillin</td><td align="right" rowspan="1" colspan="1">23</td><td align="right" rowspan="1" colspan="1">24</td><td align="right" rowspan="1" colspan="1">9</td><td align="right" rowspan="1" colspan="1">22</td><td align="right" rowspan="1" colspan="1">17</td></tr><tr><td align="center" rowspan="1" colspan="1">Erythromycin</td><td align="right" rowspan="1" colspan="1">38</td><td align="right" rowspan="1" colspan="1">34</td><td align="right" rowspan="1" colspan="1">26</td><td align="right" rowspan="1" colspan="1">28</td><td align="right" rowspan="1" colspan="1">27</td></tr><tr><td align="center" rowspan="1" colspan="1">Fusidic acid</td><td align="right" rowspan="1" colspan="1">NA</td><td align="right" rowspan="1" colspan="1">20</td><td align="right" rowspan="1" colspan="1">19</td><td align="right" rowspan="1" colspan="1">64</td><td align="right" rowspan="1" colspan="1">27</td></tr><tr><td align="center" rowspan="1" colspan="1">Gentamicin</td><td align="right" rowspan="1" colspan="1">25</td><td align="right" rowspan="1" colspan="1">21</td><td align="right" rowspan="1" colspan="1">16</td><td align="right" rowspan="1" colspan="1">24</td><td align="right" rowspan="1" colspan="1">27</td></tr><tr><td align="center" rowspan="1" colspan="1">Methicillin</td><td align="right" rowspan="1" colspan="1">23</td><td align="right" rowspan="1" colspan="1">24</td><td align="right" rowspan="1" colspan="1">9</td><td align="right" rowspan="1" colspan="1">22</td><td align="right" rowspan="1" colspan="1">17</td></tr><tr><td align="center" rowspan="1" colspan="1">Penicillin</td><td align="right" rowspan="1" colspan="1">95</td><td align="right" rowspan="1" colspan="1">95</td><td align="right" rowspan="1" colspan="1">99</td><td align="right" rowspan="1" colspan="1">96</td><td align="right" rowspan="1" colspan="1">99</td></tr><tr><td align="center" rowspan="1" colspan="1">Teicoplanin</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">TMP/SMX</td><td align="right" rowspan="1" colspan="1">24</td><td align="right" rowspan="1" colspan="1">27</td><td align="right" rowspan="1" colspan="1">31</td><td align="right" rowspan="1" colspan="1">18</td><td align="right" rowspan="1" colspan="1">94</td></tr><tr><td align="center" rowspan="1" colspan="1">Vancomycin</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td><td align="right" rowspan="1" colspan="1">0</td></tr></tbody></table></div><div id="largeobj_idm139927446485728" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T9/?report=objectonly">Open in a separate window</a></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T10"><h3>Table 10</h3><!--caption a7--><div class="caption"><p id="__p47">Average Resistance Levels of Major Bacteria in Kuwait, 1999&#x02013;2003</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927513541600" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" colspan="11" rowspan="1">unit: %</td></tr></thead><tbody><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">ECO</td><td align="center" rowspan="1" colspan="1">KPN</td><td align="center" rowspan="1" colspan="1">PAE</td><td align="center" rowspan="1" colspan="1">SPN</td><td align="center" rowspan="1" colspan="1">Shigella spp.</td><td align="center" rowspan="1" colspan="1">Salmonella spp.</td><td align="center" rowspan="1" colspan="1">Enterococcus spp.</td><td align="center" rowspan="1" colspan="1">SAU</td><td align="center" rowspan="1" colspan="1"><strong><em>Average Resistance</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>Average Growth</em></strong></td></tr><tr><td colspan="11" rowspan="1"><hr /></td></tr><tr><td align="center" rowspan="1" colspan="1">Average Annual Resistance</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1"><strong><em>27</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>17</em></strong></td></tr></tbody></table></div><div id="largeobj_idm139927513541600" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T10/?report=objectonly">Open in a separate window</a></div></div></div></div><div id="__sec12" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec12title">Discussion: Comparing antibiotic resistance in China, the U.S. and Kuwait</h2><p id="__p48" class="p p-first">In China, resistance rates exhibit a clear and rapid upward trend. In the U.S., resistance currently appears to grow at a more leisurely pace. Kuwait seems to be somewhere in between. It is important to note that the pace of growth may depend on the whether resistance to a particular antibiotic has reached a potential equilibrium. As shown in the previous data, the 3% resistance growth rate of ECO against Ciprofloxacin in China (Table <a href="/pmc/articles/PMC1502134/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1),</span></span><span>1</span></a>), is considerably lower than it is in the other two countries against similar quinolone drugs (Table <a href="/pmc/articles/PMC1502134/table/T5/" target="table" class="fig-table-link figpopup" rid-figpopup="T5" rid-ob="ob-T5" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table5</span></span><span>5</span></a> and Table <a href="/pmc/articles/PMC1502134/table/T10/" target="table" class="fig-table-link figpopup" rid-figpopup="T10" rid-ob="ob-T10" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table10).</span></span><span>10</span></a>). This is probably because ECO resistance may have virtually reached equilibrium in China by the beginning of the study period; hence it didn\'t grow much in subsequent years.</p><p id="__p49">That resistance does not grow without bound highlights the importance of comparing the current prevalence of resistance in the three countries. After all, the prevalence of resistance reflects the risk of a drug-resistant infection for any given patient. A low rate of growth is small consolation if patients already face a high baseline risk of a acquiring an expensive, debilitating and even potentially untreatable "superbug" infection.</p><p id="__p50">The prevalence of resistance also substantially differs across countries, although as noted previously, surveillance data is far from ideal in capturing the true scope of the problem. As shown in Table <a href="/pmc/articles/PMC1502134/table/T11/" target="table" class="fig-table-link figpopup" rid-figpopup="T11" rid-ob="ob-T11" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table11,</span></span><span>11</span></a>, using the data currently available, China has far higher prevalence of resistance for all the bacteria studied. For example, in China resistance of SPN to one of the oldest antibiotics, erythromycin, reaches 73%, while the figure for Kuwait is only 23%. A challenge for the U.S. is the exceptionally high level of Vancomycin-Resistant Enterococcus spp (VRE). In the U.S., 53% of Shigella spp are resistant to Trimethoprim/Sulfamethoxazole (TMP/SMX), in contrast to 0% in both of the other countries. These examples suggest that severity of resistance may be correlated with volume of usage. Vancomycin is less affordable in both China and Kuwait, presumably resulting in less usage in those countries.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T11"><h3>Table 11</h3><!--caption a7--><div class="caption"><p id="__p51">Resistance rates in China, U.S. and Kuwait, hospital surveillance data for 2001</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927514325248" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" colspan="6" rowspan="1">From Tables 1,2,3,8 and 9; Unit: %</td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Bacterium(a)</td><td align="center" rowspan="1" colspan="1">Antibiotic(s)</td><td align="center" rowspan="1" colspan="1">Pair</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">U.S.</td><td align="center" rowspan="1" colspan="1">Kuwait</td></tr><tr><td colspan="6" rowspan="1"><hr /></td></tr><tr><td align="center" rowspan="1" colspan="1">SAU</td><td align="center" rowspan="1" colspan="1">Methicillin</td><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">9</td></tr><tr><td align="center" rowspan="1" colspan="1">SPN</td><td align="center" rowspan="1" colspan="1">Erythromycin</td><td align="center" rowspan="1" colspan="1">B</td><td align="center" rowspan="1" colspan="1">73</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">23</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Cefotaxime</td><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="center" rowspan="1" colspan="1"><em>Enterococcus spp</em></td><td align="center" rowspan="1" colspan="1">Vancomycin</td><td align="center" rowspan="1" colspan="1">D</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1"><em>ECO</em></td><td align="center" rowspan="1" colspan="1">Ceftazidime</td><td align="center" rowspan="1" colspan="1">E</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">1*</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Cefotaxime</td><td align="center" rowspan="1" colspan="1">F</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">1*</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">1*</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ciprofloxacin/Ofloxacin</td><td align="center" rowspan="1" colspan="1">H</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">26</td></tr><tr><td align="center" rowspan="1" colspan="1">PAE</td><td align="center" rowspan="1" colspan="1">Ceftazidime</td><td align="center" rowspan="1" colspan="1">I</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ciprofloxacin/Ofloxacin</td><td align="center" rowspan="1" colspan="1">J</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">31</td></tr><tr><td align="center" rowspan="1" colspan="1">KPN</td><td align="center" rowspan="1" colspan="1">Ceftazidime</td><td align="center" rowspan="1" colspan="1">K</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">4*</td><td align="center" rowspan="1" colspan="1">14</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Cefotaxime</td><td align="center" rowspan="1" colspan="1">L</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">4*</td><td align="center" rowspan="1" colspan="1">13</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1">M</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">4*</td><td align="center" rowspan="1" colspan="1">13</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ciprofloxacin</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">12**[27]</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td align="center" rowspan="1" colspan="1"><em>Salmonella </em>spp</td><td align="center" rowspan="1" colspan="1">Amoxicillin-clavulanate</td><td align="center" rowspan="1" colspan="1">O</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ciprofloxacin</td><td align="center" rowspan="1" colspan="1">Q</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.4</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">TMP/SMX***</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Gentamicin</td><td align="center" rowspan="1" colspan="1">S</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1"><em>Shigella </em>spp</td><td align="center" rowspan="1" colspan="1">Amoxicillin-clavulanate</td><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">20</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1">U</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ciprofloxacin</td><td align="center" rowspan="1" colspan="1">V</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">TMP/SMX</td><td align="center" rowspan="1" colspan="1">W</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Gentamicin</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">0.2</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><strong><em>Average</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>17</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>7</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>9</em></strong></td></tr></tbody></table></div><div id="largeobj_idm139927514325248" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T11/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p52">* The original U.S. NNIS reported resistance rates to either one of the Cef3 drugs, i.e. ceftazidime, cefotaxime or ceftriaxone. We assume the same rates for each drug.</p><p id="__p53">** Based on surveillance of ICU patients</p><p id="__p54">*** TMP/SMX = Trimethoprim/Sulfamethoxazole</p></div></div><p id="__p55" class="p">Table <a href="/pmc/articles/PMC1502134/table/T12/" target="table" class="fig-table-link figpopup" rid-figpopup="T12" rid-ob="ob-T12" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table12</span></span><span>12</span></a> compares the three countries with Japan and Taiwan regarding prevalence of three important drug-resistant bacteria: MRSA, penicillin resistant SPN (PRSP) and vancomycin-resistant <em>Enterococcus </em>spp (VRE) [<a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916175">32</a>-<a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916165">34</a>]. Interestingly, each country has its own most problematic resistance culprit. For China, MRSA is the biggest threat, where resistance among hospital-acquired infections reaches almost 90%, the highest among the five countries. For the U.S., VRE is high. VRE growth in the U.S. can be traced to the late 1980s and is probably among the highest in the world. For Kuwait, PRSP is considerable. Both Taiwan and Japan are also troubled by at least one of these three resistant bacteria.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T12"><h3>Table 12</h3><!--caption a7--><div class="caption"><p id="__p56">MRSA, PRSP &#x00026; VRE in Selected Countries</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927436366864" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" colspan="4" rowspan="1">Unit: %</td></tr></thead><tbody><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">MRSA (HAI only)</td><td align="center" rowspan="1" colspan="1">PRSP</td><td align="center" rowspan="1" colspan="1">VRE</td></tr><tr><td colspan="4" rowspan="1"><hr /></td></tr><tr><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">89 (2001)</td><td align="center" rowspan="1" colspan="1">27 (2001)</td><td align="center" rowspan="1" colspan="1">0 (2001)</td></tr><tr><td align="center" rowspan="1" colspan="1">U.S.</td><td align="center" rowspan="1" colspan="1">16 (2001)</td><td align="center" rowspan="1" colspan="1">26 (2001)</td><td align="center" rowspan="1" colspan="1">0.3 (1989), 8 (1993), 12.8 (2001) in ICU</td></tr><tr><td align="center" rowspan="1" colspan="1">Kuwait</td><td align="center" rowspan="1" colspan="1">9 (2001)</td><td align="center" rowspan="1" colspan="1">46 (2001)</td><td align="center" rowspan="1" colspan="1">0 (2001)</td></tr><tr><td align="center" rowspan="1" colspan="1">Japan [33]</td><td align="center" rowspan="1" colspan="1">60&#x02013;80% (1999)</td><td align="center" rowspan="1" colspan="1">11&#x02013;40 (1999)</td><td align="center" rowspan="1" colspan="1">n/a</td></tr><tr><td align="center" rowspan="1" colspan="1">Taiwan [34]</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">69 (2000)</td><td align="center" rowspan="1" colspan="1">2 (2000)</td></tr></tbody></table></div><div id="largeobj_idm139927436366864" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T12/?report=objectonly">Open in a separate window</a></div></div><div id="__sec13" class="sec sec-last"><h3 id="__sec13title">Resistance correlations</h3><p id="__p57" class="p p-first">How similar or different are resistance patterns in different countries? Does transmission travel across national borders as humans do? If so, do countries\' resistance patterns converge? To begin to examine this issue, we construct coefficients of resistance correlation among China, U.S. and Kuwait. We rank resistance rates for 24 bug-drug pairs and define perfect correlation as each bug-drug pair displaying the same resistance rank. Perfect negative correlation exists if the ranks in two countries go in precisely the opposite order. Table <a href="/pmc/articles/PMC1502134/table/T13/" target="table" class="fig-table-link figpopup" rid-figpopup="T13" rid-ob="ob-T13" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table13</span></span><span>13</span></a> reports the correlation coefficient for each pair of countries. The statistic by definition is bounded between -1 and 1, where -1 means perfect disagreement while 1 means perfect agreement. Thus the bigger the statistic, the more correlated two countries\' resistance patterns are.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T13"><h3>Table 13</h3><!--caption a7--><div class="caption"><p id="__p58">Ranks of resistance rates in China, U.S. and Kuwait, 2001(Rank correlations at bottom of table)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927446423408" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" rowspan="1" colspan="1">Bacterium(a)</td><td align="center" rowspan="1" colspan="1">Antibiotic(s)</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">U.S.</td><td align="center" rowspan="1" colspan="1">Kuwait</td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">SAU</td><td align="center" rowspan="1" colspan="1">Methicillin</td><td align="center" rowspan="1" colspan="1"><em>3</em></td><td align="center" rowspan="1" colspan="1"><em>2</em></td><td align="center" rowspan="1" colspan="1"><em>11</em></td></tr><tr><td align="center" rowspan="1" colspan="1">SPN</td><td align="center" rowspan="1" colspan="1">Erythromycin</td><td align="center" rowspan="1" colspan="1"><em>1</em></td><td align="center" rowspan="1" colspan="1"><em>4</em></td><td align="center" rowspan="1" colspan="1"><em>4</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Cefotaxime</td><td align="center" rowspan="1" colspan="1"><em>21</em></td><td align="center" rowspan="1" colspan="1"><em>5</em></td><td align="center" rowspan="1" colspan="1"><em>14</em></td></tr><tr><td align="center" rowspan="1" colspan="1"><em>Enterococcus spp</em></td><td align="center" rowspan="1" colspan="1">Vancomycin</td><td align="center" rowspan="1" colspan="1"><em>20</em></td><td align="center" rowspan="1" colspan="1"><em>7</em></td><td align="center" rowspan="1" colspan="1"><em>17</em></td></tr><tr><td align="center" rowspan="1" colspan="1">ECO</td><td align="center" rowspan="1" colspan="1">Ceftazidime</td><td align="center" rowspan="1" colspan="1"><em>15</em></td><td align="center" rowspan="1" colspan="1"><em>17</em></td><td align="center" rowspan="1" colspan="1"><em>13</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Cefotaxime</td><td align="center" rowspan="1" colspan="1"><em>8</em></td><td align="center" rowspan="1" colspan="1"><em>18</em></td><td align="center" rowspan="1" colspan="1"><em>15</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1"><em>6</em></td><td align="center" rowspan="1" colspan="1"><em>19</em></td><td align="center" rowspan="1" colspan="1"><em>16</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ciprofloxacin/Ofloxacin</td><td align="center" rowspan="1" colspan="1"><em>2</em></td><td align="center" rowspan="1" colspan="1"><em>13</em></td><td align="center" rowspan="1" colspan="1"><em>3</em></td></tr><tr><td align="center" rowspan="1" colspan="1">PAE</td><td align="center" rowspan="1" colspan="1">Ceftazidime</td><td align="center" rowspan="1" colspan="1"><em>11</em></td><td align="center" rowspan="1" colspan="1"><em>8</em></td><td align="center" rowspan="1" colspan="1"><em>2</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ciprofloxacin/Ofloxacin</td><td align="center" rowspan="1" colspan="1"><em>5</em></td><td align="center" rowspan="1" colspan="1"><em>3</em></td><td align="center" rowspan="1" colspan="1"><em>1</em></td></tr><tr><td align="center" rowspan="1" colspan="1">KPN</td><td align="center" rowspan="1" colspan="1">Ceftazidime</td><td align="center" rowspan="1" colspan="1"><em>16</em></td><td align="center" rowspan="1" colspan="1"><em>9</em></td><td align="center" rowspan="1" colspan="1"><em>7</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Cefotaxime</td><td align="center" rowspan="1" colspan="1"><em>12</em></td><td align="center" rowspan="1" colspan="1"><em>10</em></td><td align="center" rowspan="1" colspan="1"><em>8</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1"><em>7</em></td><td align="center" rowspan="1" colspan="1"><em>11</em></td><td align="center" rowspan="1" colspan="1"><em>9</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ciprofloxacin</td><td align="center" rowspan="1" colspan="1"><em>9</em></td><td align="center" rowspan="1" colspan="1"><em>6</em></td><td align="center" rowspan="1" colspan="1"><em>6</em></td></tr><tr><td align="center" rowspan="1" colspan="1"><em>Salmonella </em>spp</td><td align="center" rowspan="1" colspan="1">Amoxicillin-clavulanate</td><td align="center" rowspan="1" colspan="1"><em>13</em></td><td align="center" rowspan="1" colspan="1"><em>12</em></td><td align="center" rowspan="1" colspan="1"><em>12</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1"><em>19</em></td><td align="center" rowspan="1" colspan="1"><em>20</em></td><td align="center" rowspan="1" colspan="1"><em>18</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ciprofloxacin</td><td align="center" rowspan="1" colspan="1"><em>22</em></td><td align="center" rowspan="1" colspan="1"><em>21</em></td><td align="center" rowspan="1" colspan="1"><em>10</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">TMP/SMX</td><td align="center" rowspan="1" colspan="1"><em>23</em></td><td align="center" rowspan="1" colspan="1"><em>14</em></td><td align="center" rowspan="1" colspan="1"><em>19</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Gentamicin</td><td align="center" rowspan="1" colspan="1"><em>14</em></td><td align="center" rowspan="1" colspan="1"><em>15</em></td><td align="center" rowspan="1" colspan="1"><em>20</em></td></tr><tr><td align="center" rowspan="1" colspan="1"><em>Shigella </em>spp</td><td align="center" rowspan="1" colspan="1">Amoxicillin-clavulanate</td><td align="center" rowspan="1" colspan="1"><em>4</em></td><td align="center" rowspan="1" colspan="1"><em>16</em></td><td align="center" rowspan="1" colspan="1"><em>5</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1"><em>17</em></td><td align="center" rowspan="1" colspan="1"><em>23</em></td><td align="center" rowspan="1" colspan="1"><em>21</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Ciprofloxacin</td><td align="center" rowspan="1" colspan="1"><em>18</em></td><td align="center" rowspan="1" colspan="1"><em>24</em></td><td align="center" rowspan="1" colspan="1"><em>22</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">TMP/SMX</td><td align="center" rowspan="1" colspan="1"><em>24</em></td><td align="center" rowspan="1" colspan="1"><em>1</em></td><td align="center" rowspan="1" colspan="1"><em>23</em></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">Gentamicin</td><td align="center" rowspan="1" colspan="1"><em>10</em></td><td align="center" rowspan="1" colspan="1"><em>22</em></td><td align="center" rowspan="1" colspan="1"><em>24</em></td></tr><tr><td align="center" colspan="2" rowspan="1"><strong><em>Correlation Coefficients</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>CHN_US: 0.18</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>US_KW: 0.46</em></strong></td><td align="center" rowspan="1" colspan="1"><strong><em>CHN_KW: 0.60</em></strong></td></tr></tbody></table></div><div id="largeobj_idm139927446423408" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1502134/table/T13/?report=objectonly">Open in a separate window</a></div></div><p id="__p59">Of course, methods for aggregation and comparing patterns of resistance across countries and over time should be improved, and applied more fruitfully with better data from increased local and global surveillance. But even this preliminary analysis reveals some interesting patterns. For example, resistance rates in China are much more strongly correlated with those in Kuwait than those in the U.S. This correlation pattern suggests that at least in the short run, resistance in a country is more likely to be determined by endogenous factors (such as strictness of practices for prescribing drugs). In the long run, the frequency and magnitude of contacts among nations with different resistance problems is likely to be critical. Because Kuwait and China are relatively isolated countries, it is less surprising that their antibiotic resistance problems show domestic characters. However, as we expect them to be opening more to the world, particularly China, the problem may worsen when these countries can increasingly export and import antibiotic resistance. China, the most populous country in the world and an economy with the highest growth, is particularly likely to exacerbate the problem. As illustrated in Figure <a href="/pmc/articles/PMC1502134/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1,</span></span><span>1</span></a>, the number of Chinese departures to overseas destinations has been growing at increasing rates in the past decade and continues to show upward momentum in recent years.</p><p id="__p60" class="p p-last">No doubt, there are also complex interactions with levels of economic well- being. Drugs become more affordable as countries become richer, but they are likely to be given out more carefully, particularly since concerns about resistance also increase. The critical question for policy is whether countries can control their own resistance problems, and also avoid importing the problem from abroad.</p></div></div><div id="__sec14" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec14title">Conclusion</h2><p id="__p61" class="p p-first">We have outlined the nature of the antimicrobial resistance problem as an important health and cost issue for three quite disparate nations, and by inference for a broad swath of the world\'s population. Surprisingly, this issue virtually never receives prominent attention at the national or international level, despite its scope and potentially devastating impact on global public health in the coming decades.</p><p id="__p62">We examined antimicrobial resistance data for China, Kuwait, and the United States. In each country, we looked at specific infectious agents and their resistance to particular antibiotics or other antimicrobials. Though an upward trend of resistance is found broadly, the patterns of correlation between countries\' resistance rates suggest predominantly independent profiles. But we would expect greater convergence as globalization increases contacts between different nations\' populations, raising questions about how to coordinate an effective international response [<a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_132916173">35</a>].</p><p id="__p63" class="p p-last">Future research should develop better methods of data aggregation, explore the patterns of drug resistance across more countries, analyze the determinants of transmission of drug resistance across national boundaries, and assess how those determinants are progressing. Individuals everywhere would benefit if far greater attention were paid to the problem of antimicrobial resistance.</p></div><div id="__sec15" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec15title">Competing interests</h2><p id="__p64" class="p p-first-last">The author(s) declare that they have no competing interests.</p></div><div id="__sec16" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec16title">Authors\' contributions</h2><p id="__p65" class="p p-first-last">RFZ assembled the data, carried out the analysis and drafted the manuscript. KE and RJZ conceived of the study, participated in its design and coordination, and helped to draft the manuscript. VR provided the Kuwait data and helped to draft the manuscript. All authors read and approved the manuscript.</p></div><div id="idm139927435589920" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139927435589920title">Acknowledgements</h2><div class="sec"><div id="__sec17" class="sec sec-first"><h3 id="__sec17title"></h3><p id="__p66" class="p p-first-last">The authors gratefully acknowledge financial support from the Kuwait Foundation for the Advancement of Sciences through the John F. Kennedy School of Government at Harvard University.</p></div></div></div><div id="idm139927439723440" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139927439723440title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="B1"><span class="citation">Kimball AM, Arima Y, Hodges RH. Trade related infections: farther, faster, quieter. <span><span class="ref-journal">Globalization and Health. </span>2005;<span class="ref-vol">1</span>:3. doi: 10.1186/1744-8603-1-3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1143781/">PMC free article</a>]</span> [<a href="/pubmed/15847684" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1744-8603-1-3" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Globalization+and+Health&amp;title=Trade+related+infections:+farther,+faster,+quieter&amp;author=AM+Kimball&amp;author=Y+Arima&amp;author=RH+Hodges&amp;volume=1&amp;publication_year=2005&amp;pages=3&amp;pmid=15847684&amp;doi=10.1186/1744-8603-1-3&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B2"><span class="citation">Hodges RH, Kimball AM. The global diet: trade and novel infections. <span><span class="ref-journal">Globalization and Health. </span>2005;<span class="ref-vol">1</span>:4. doi: 10.1186/1744-8603-1-4.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1143782/">PMC free article</a>]</span> [<a href="/pubmed/15847691" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1744-8603-1-4" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Globalization+and+Health&amp;title=The+global+diet:+trade+and+novel+infections&amp;author=RH+Hodges&amp;author=AM+Kimball&amp;volume=1&amp;publication_year=2005&amp;pages=4&amp;pmid=15847691&amp;doi=10.1186/1744-8603-1-4&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B3"><span class="citation">Wilson KH, Blitchington RB. Human colonic biota studied by ribosomal DNA sequence analysis. <span><span class="ref-journal">Appl Environ Microbiol. </span><span class="ref-vol">62</span>:2273\xe2\x80\x932278.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC168008/">PMC free article</a>]</span> [<a href="/pubmed/8779565" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Appl+Environ+Microbiol&amp;title=Human+colonic+biota+studied+by+ribosomal+DNA+sequence+analysis&amp;author=KH+Wilson&amp;author=RB+Blitchington&amp;volume=62&amp;pages=2273-2278&amp;pmid=8779565&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B4"><span class="citation">Institute of Medicine  Emerging infections: microbial threats to health in the United States. <span class="ref-journal">National Academy Press.</span> 1994. </span></li><li id="B5"><span class="citation">Wilson KH, Blitchington RB. Human colonic biota studied by ribosomal DNA sequence analysis. <span><span class="ref-journal">Appl Environ Microbiol. </span><span class="ref-vol">62</span>:2273\xe2\x80\x938.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC168008/">PMC free article</a>]</span> [<a href="/pubmed/8779565" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Appl+Environ+Microbiol&amp;title=Human+colonic+biota+studied+by+ribosomal+DNA+sequence+analysis&amp;author=KH+Wilson&amp;author=RB+Blitchington&amp;volume=62&amp;pages=2273-8&amp;pmid=8779565&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B6"><span class="citation">Davies J. Bacteria on the rampage. <span><span class="ref-journal">Nature. </span>1996;<span class="ref-vol">383</span>:219\xe2\x80\x93220. doi: 10.1038/383219a0.</span> [<a href="/pubmed/8805692" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F383219a0" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Bacteria+on+the+rampage&amp;author=J+Davies&amp;volume=383&amp;publication_year=1996&amp;pages=219-220&amp;pmid=8805692&amp;doi=10.1038/383219a0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B7"><span class="citation">Field HJ, Coen DM. Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. <span><span class="ref-journal">J Virol. </span>1986;<span class="ref-vol">60</span>:286\xe2\x80\x93289.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC253927/">PMC free article</a>]</span> [<a href="/pubmed/3018291" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Pathogenicity+of+herpes+simplex+virus+mutants+containing+drug+resistance+mutations+in+the+viral+DNA+polymerase+gene&amp;author=HJ+Field&amp;author=DM+Coen&amp;volume=60&amp;publication_year=1986&amp;pages=286-289&amp;pmid=3018291&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B8"><span class="citation">Muder RR, Brennen C, Wagener MM, et al.  Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993&#x02013;1995) analysis. <span><span class="ref-journal">J Clin Microbiol. </span>1996;<span class="ref-vol">34</span>:2537\xe2\x80\x932543.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC229313/">PMC free article</a>]</span> [<a href="/pubmed/8880516" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Temporal+shifts+in+traits+of+Vibrio+cholerae+strains+isolated+from+hospitalized+patients+in+Calcutta:+a+3-year+(1993&#x02013;1995)+analysis&amp;author=RR+Muder&amp;author=C+Brennen&amp;author=MM+Wagener&amp;volume=34&amp;publication_year=1996&amp;pages=2537-2543&amp;pmid=8880516&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B9"><span class="citation">Bisognano C, et al.  Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. <span><span class="ref-journal">Antimicrob Agents Chemother. </span>1997;<span class="ref-vol">41</span>:906\xe2\x80\x93913.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC163823/">PMC free article</a>]</span> [<a href="/pubmed/9145842" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob+Agents+Chemother&amp;title=Increased+expression+of+fibronectin-binding+proteins+by+fluoroquinolone-resistant+Staphylococcus+aureus+exposed+to+subinhibitory+levels+of+ciprofloxacin&amp;author=C+Bisognano&amp;volume=41&amp;publication_year=1997&amp;pages=906-913&amp;pmid=9145842&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B10"><span class="citation">World Health Organization  WHO Global Strategy for Containment of Antimicrobial Resistance. <span class="ref-journal">Geneva.</span> 2001. </span></li><li id="B11"><span class="citation">Arason VA, Kristinsson KG, et al.  Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. <span><span class="ref-journal">BMJ. </span>1996;<span class="ref-vol">313</span>:387\xe2\x80\x9391.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2351797/">PMC free article</a>]</span> [<a href="/pubmed/8761224" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Do+antimicrobials+increase+the+carriage+rate+of+penicillin+resistant+pneumococci+in+children?+Cross+sectional+prevalence+study&amp;author=VA+Arason&amp;author=KG+Kristinsson&amp;volume=313&amp;publication_year=1996&amp;pages=387-91&amp;pmid=8761224&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B12"><span class="citation">Seppala H, Klaukka T, et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. <span><span class="ref-journal">N Engl J Med. </span>1997;<span class="ref-vol">337</span>:441\xe2\x80\x936. doi: 10.1056/NEJM199708143370701.</span> [<a href="/pubmed/9250845" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM199708143370701" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=The+effect+of+changes+in+the+consumption+of+macrolide+antibiotics+on+erythromycin+resistance+in+group+A+streptococci+in+Finland.+Finnish+Study+Group+for+Antimicrobial+Resistance&amp;author=H+Seppala&amp;author=T+Klaukka&amp;volume=337&amp;publication_year=1997&amp;pages=441-6&amp;pmid=9250845&amp;doi=10.1056/NEJM199708143370701&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B13"><span class="citation">Levy SB, Fitzgerald GB, Macone AB. Spread of Antibiotic-Resistant Plasmids from Chicken to Chicken and from Chicken to Man. <span><span class="ref-journal">Nature. </span>1976;<span class="ref-vol">260</span>:40\xe2\x80\x9342. doi: 10.1038/260040a0.</span> [<a href="/pubmed/772441" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F260040a0" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Spread+of+Antibiotic-Resistant+Plasmids+from+Chicken+to+Chicken+and+from+Chicken+to+Man&amp;author=SB+Levy&amp;author=GB+Fitzgerald&amp;author=AB+Macone&amp;volume=260&amp;publication_year=1976&amp;pages=40-42&amp;pmid=772441&amp;doi=10.1038/260040a0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B14"><span class="citation">Levy SB, Fitzgerald GB, Macone AB. Changes in Intestinal Flora of Farm Personnel after Introduction of a Tetracycline-Supplemented Feed on a Farm. <span><span class="ref-journal">N Engl J Med. </span>1976;<span class="ref-vol">295</span>:583\xe2\x80\x93588.</span> [<a href="/pubmed/950974" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Changes+in+Intestinal+Flora+of+Farm+Personnel+after+Introduction+of+a+Tetracycline-Supplemented+Feed+on+a+Farm&amp;author=SB+Levy&amp;author=GB+Fitzgerald&amp;author=AB+Macone&amp;volume=295&amp;publication_year=1976&amp;pages=583-588&amp;pmid=950974&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B15"><span class="citation">Witte W. Selective pressure by antibiotic use in livestock. <span><span class="ref-journal">Int J Antimicrob Agents. </span>2000;<span class="ref-vol">16</span>:S19\xe2\x80\x9324.</span> Review. [<a href="/pubmed/11137404" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Antimicrob+Agents&amp;title=Selective+pressure+by+antibiotic+use+in+livestock&amp;author=W+Witte&amp;volume=16&amp;publication_year=2000&amp;pages=S19-24&amp;pmid=11137404&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B16"><span class="citation">Breathnach AS, de Ruiter A, Holdsworth GM, et al.  An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. <span><span class="ref-journal">J Hosp Infect. </span>1998;<span class="ref-vol">39</span>:111\xe2\x80\x93117. doi: 10.1016/S0195-6701(98)90324-3.</span> [<a href="/pubmed/9651855" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0195-6701(98)90324-3" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hosp+Infect&amp;title=An+outbreak+of+multi-drug-resistant+tuberculosis+in+a+London+teaching+hospital&amp;author=AS+Breathnach&amp;author=A+de+Ruiter&amp;author=GM+Holdsworth&amp;volume=39&amp;publication_year=1998&amp;pages=111-117&amp;pmid=9651855&amp;doi=10.1016/S0195-6701(98)90324-3&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B17"><span class="citation">Hannan MM, Azadian BS, Gazzard BG, et al.  Hospital infection control in an era of HIV infection and multi-drug resistant tuberculosis. <span><span class="ref-journal">J Hosp Infect. </span>2000;<span class="ref-vol">44</span>:5\xe2\x80\x9311. doi: 10.1053/jhin.1999.0651.</span> [<a href="/pubmed/10633047" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1053%2Fjhin.1999.0651" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hosp+Infect&amp;title=Hospital+infection+control+in+an+era+of+HIV+infection+and+multi-drug+resistant+tuberculosis&amp;author=MM+Hannan&amp;author=BS+Azadian&amp;author=BG+Gazzard&amp;volume=44&amp;publication_year=2000&amp;pages=5-11&amp;pmid=10633047&amp;doi=10.1053/jhin.1999.0651&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B18"><span class="citation">Martin MA. Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. <span><span class="ref-journal">Curr Clin Top Infect Dis. </span>1994;<span class="ref-vol">14</span>:170\xe2\x80\x93191.</span> [<a href="/pubmed/8086114" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Clin+Top+Infect+Dis&amp;title=Methicillin-resistant+Staphylococcus+aureus:+the+persistent+resistant+nosocomial+pathogen&amp;author=MA+Martin&amp;volume=14&amp;publication_year=1994&amp;pages=170-191&amp;pmid=8086114&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B19"><span class="citation">Wang F, Zhu D, et al.  Surveillance of bacterial resistance in Shanghai. <span><span class="ref-journal">Chin J Infect Chemother. </span>2002;<span class="ref-vol">2</span>:1\xe2\x80\x939.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chin+J+Infect+Chemother&amp;title=Surveillance+of+bacterial+resistance+in+Shanghai&amp;author=F+Wang&amp;author=D+Zhu&amp;volume=2&amp;publication_year=2002&amp;pages=1-9&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B20"><span class="citation">Cox RA, Conquest C, Malaghan C, et al.  A major outbreak of methicillin-resistant Staphylococcus aureus caused by new phage-type (EMRSA-16) <span><span class="ref-journal">J Hosp Infect. </span>1995;<span class="ref-vol">29</span>:87\xe2\x80\x93106. doi: 10.1016/0195-6701(95)90191-4.</span> [<a href="/pubmed/7759837" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0195-6701(95)90191-4" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hosp+Infect&amp;title=A+major+outbreak+of+methicillin-resistant+Staphylococcus+aureus+caused+by+new+phage-type+(EMRSA-16)&amp;author=RA+Cox&amp;author=C+Conquest&amp;author=C+Malaghan&amp;volume=29&amp;publication_year=1995&amp;pages=87-106&amp;pmid=7759837&amp;doi=10.1016/0195-6701(95)90191-4&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B21"><span class="citation">Astagneau P, et al.  Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey. <span><span class="ref-journal">J Hosp Infect. </span>1999;<span class="ref-vol">42</span>:303\xe2\x80\x93312. doi: 10.1053/jhin.1998.0612.</span> [<a href="/pubmed/10467544" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1053%2Fjhin.1998.0612" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hosp+Infect&amp;title=Cost+of+antimicrobial+treatment+for+nosocomial+infections+based+on+a+French+prevalence+survey&amp;author=P+Astagneau&amp;volume=42&amp;publication_year=1999&amp;pages=303-312&amp;pmid=10467544&amp;doi=10.1053/jhin.1998.0612&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B22"><span class="citation">Haley RW, Morgan WM, Culver DH, et al.  Update from the SENIC project. Hospital infection control: Recent progress and opportunities under prospective payment. <span><span class="ref-journal">Am J Infect Control. </span>1985;<span class="ref-vol">13</span>:97\xe2\x80\x93108. doi: 10.1016/0196-6553(85)90085-9.</span> [<a href="/pubmed/3849273" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0196-6553(85)90085-9" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Infect+Control&amp;title=Update+from+the+SENIC+project.+Hospital+infection+control:+Recent+progress+and+opportunities+under+prospective+payment&amp;author=RW+Haley&amp;author=WM+Morgan&amp;author=DH+Culver&amp;volume=13&amp;publication_year=1985&amp;pages=97-108&amp;pmid=3849273&amp;doi=10.1016/0196-6553(85)90085-9&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B23"><span class="citation">Duckworth GJ. Diagnosis and management of methicillin-resistant Staphylococcus aureus infection. <span><span class="ref-journal">British Medical Journal. </span>1993;<span class="ref-vol">307</span>:1049\xe2\x80\x931052.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1679223/">PMC free article</a>]</span> [<a href="/pubmed/8251781" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=British+Medical+Journal&amp;title=Diagnosis+and+management+of+methicillin-resistant+Staphylococcus+aureus+infection&amp;author=GJ+Duckworth&amp;volume=307&amp;publication_year=1993&amp;pages=1049-1052&amp;pmid=8251781&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B24"><span class="citation">Tsiodras S, Gold H, et al.  Linezolid resistance in a clinical isolate of Staphylococcus aureus. <span><span class="ref-journal">Lancet. </span>2001;<span class="ref-vol">358</span>:207\xe2\x80\x93208. doi: 10.1016/S0140-6736(01)05410-1.</span> [<a href="/pubmed/11476839" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(01)05410-1" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Linezolid+resistance+in+a+clinical+isolate+of+Staphylococcus+aureus&amp;author=S+Tsiodras&amp;author=H+Gold&amp;volume=358&amp;publication_year=2001&amp;pages=207-208&amp;pmid=11476839&amp;doi=10.1016/S0140-6736(01)05410-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B25"><span class="citation">Chen H, Ma Y, National Antimicrobial Resistance Surveillance Center et al.  The Changing Patterns of Ciprofloxacin Resistant Bacteria Strains Isolated from Fifty Hospitals in China from 1994 to 2000. <span><span class="ref-journal">Chin J Infect Chemotherapy. </span>2002;<span class="ref-vol">2</span>:43\xe2\x80\x9345.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chin+J+Infect+Chemotherapy&amp;title=The+Changing+Patterns+of+Ciprofloxacin+Resistant+Bacteria+Strains+Isolated+from+Fifty+Hospitals+in+China+from+1994+to+2000&amp;author=H+Chen&amp;author=Y+Ma&amp;volume=2&amp;publication_year=2002&amp;pages=43-45&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B26"><span class="citation">Li J, Li G, Wang J. Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections. <span><span class="ref-journal">Natl Med J China. </span>2003;<span class="ref-vol">83</span>:365\xe2\x80\x93374.</span> (in Chinese) [<a href="/pubmed/12820911" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Natl+Med+J+China&amp;title=Surveillance+on+gram-positive+bacteria+isolated+from+patients+with+hospital+acquired+infections+or+community+acquired+infections&amp;author=J+Li&amp;author=G+Li&amp;author=J+Wang&amp;volume=83&amp;publication_year=2003&amp;pages=365-374&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B27"><span class="citation">Li J, Li G, Wang J. Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections. <span><span class="ref-journal">Natl Med J China. </span>2003;<span class="ref-vol">83</span>:1035\xe2\x80\x931045.</span> (in Chinese) [<a href="/pubmed/12820911" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Natl+Med+J+China&amp;title=Surveillance+on+gram-positive+bacteria+isolated+from+patients+with+hospital+acquired+infections+or+community+acquired+infections&amp;author=J+Li&amp;author=G+Li&amp;author=J+Wang&amp;volume=83&amp;publication_year=2003&amp;pages=1035-1045&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B28"><span class="citation">National Nosocomial Infections Surveillance System. 2001. <a href="http://www.cdc.gov/ncidod/hip/SURVEILL/nnis_pubs.HTM." data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.cdc.gov/ncidod/hip/SURVEILL/nnis_pubs.HTM.</a> report.</span></li><li id="B29"><span class="citation">National Antimicrobial Resistance Monitoring System for Enteric Bacteria. 2002. <a href="http://www.cdc.gov/narms/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.cdc.gov/narms/</a> report.</span></li><li id="B30"><span class="citation">Active Bacterial Core Surveillance. 2001. <a href="http://www.cdc.gov/ncidod/dbmd/abcs/reports.htm." data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.cdc.gov/ncidod/dbmd/abcs/reports.htm.</a> report.</span></li><li id="B31"><span class="citation">Eggleston KE, Rotimi V, Ghayda A, Zhang R, Zeckhauser RJ. An economic analysis of antimicrobial resistance in Kuwait. <span class="ref-journal">J Antimicrobial Chemotherapy.</span>  Forthcoming.</span></li><li id="B32"><span class="citation">Neuhauser MM. Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. <span><span class="ref-journal">JAMA. </span>2003;<span class="ref-vol">289</span>:885\xe2\x80\x93888. doi: 10.1001/jama.289.7.885.</span> [<a href="/pubmed/12588273" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Fjama.289.7.885" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Antibiotic+resistance+among+Gram-negative+bacilli+in+US+intensive+care+units:+implications+for+fluoroquinolone+use&amp;author=MM+Neuhauser&amp;volume=289&amp;publication_year=2003&amp;pages=885-888&amp;pmid=12588273&amp;doi=10.1001/jama.289.7.885&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B33"><span class="citation">Sun Z. Antimicrobial resistance and clinical interventions. <span><span class="ref-journal">Adverse Drug Reaction J. </span>2003;<span class="ref-vol">3</span>:151\xe2\x80\x93155.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adverse+Drug+Reaction+J&amp;title=Antimicrobial+resistance+and+clinical+interventions&amp;author=Z+Sun&amp;volume=3&amp;publication_year=2003&amp;pages=151-155&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B34"><span class="citation">McDonald LC, Lauderdale T, et al.  The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme 2000. <span><span class="ref-journal">Int J Antimicrob Agents. </span>2004;<span class="ref-vol">23</span>:362\xe2\x80\x93370. doi: 10.1016/j.ijantimicag.2003.09.021.</span> [<a href="/pubmed/15081085" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.ijantimicag.2003.09.021" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Antimicrob+Agents&amp;title=The+status+of+antimicrobial+resistance+in+Taiwan+among+Gram-positive+pathogens:+the+Taiwan+Surveillance+of+Antimicrobial+Resistance+(TSAR)+programme+2000&amp;author=LC+McDonald&amp;author=T+Lauderdale&amp;volume=23&amp;publication_year=2004&amp;pages=362-370&amp;pmid=15081085&amp;doi=10.1016/j.ijantimicag.2003.09.021&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B35"><span class="citation">Fidler DP. Globalization, international law, and emerging infectious diseases. <span><span class="ref-journal">Emerg Infect Dis. </span>1996;<span class="ref-vol">2</span>:77\xe2\x80\x9384.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2639823/">PMC free article</a>]</span> [<a href="/pubmed/8903206" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Emerg+Infect+Dis&amp;title=Globalization,+international+law,+and+emerging+infectious+diseases&amp;author=DP+Fidler&amp;volume=2&amp;publication_year=1996&amp;pages=77-84&amp;pmid=8903206&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1502134&amp;issue-id=127943&amp;journal-id=318&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Globalization and Health</span> are provided here courtesy of <strong>BioMed Central</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1502134/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1502134/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1502134/pdf/1744-8603-2-6.pdf">PDF (377K)</a></li> | <li><a href="#" data-citationid="PMC1502134" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1502134%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1502134%2F&amp;text=Antibiotic%20resistance%20as%20a%20global%20threat%3A%20Evidence%20from%20China%2C%20Kuwait%20and%20the%20United%20States"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1502134%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="16603071" data-aiid="1502134" data-aid="1502134" data-iid="127943" data-domainid="318" data-domain="globhlth" data-accid="PMC1502134" data-md5="5c56b63c3ef553cab6f4061be68aec2e"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:16:25-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A08BFE99A45910000000004F304F3&amp;ncbi_session=8A1A08BFE99AC281_1267SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1502134%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=globhlth&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1502134/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A08BFE99AC281_1267SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'